Medicaid

The Centers for Medicare & Medicaid Services Friday released guidance for states implementing two Medicaid provisions in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018.
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the Prescription Drug Pricing Reduction Act of 2019.
The Centers for Medicare & Medicaid Services plans to convene workgroups and technical expert panels to develop a “streamlined, comprehensive approach to monitoring access across Medicaid delivery systems,” the agency announced yesterday.
The Centers for Medicare & Medicaid Services today proposed rescinding a 2015 rule that required states to develop and submit access monitoring review plans to CMS for some Medicaid services.
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders.
The Centers for Medicare & Medicaid Services yesterday approved Louisiana’s Medicaid plan amendment allowing supplemental rebate agreement negotiations with prescription drug makers for Hepatitis C therapies.
The Centers for Medicare & Medicaid Services last week issued guidance outlining certain assurances that state Medicaid agencies should make “to ensure that program resources are reserved for those who meet eligibility requirements.”
The AHA today urged the Office of Management and Budget to continue using the Consumer Price Index for All Urban Consumers (CPI-U) in making annual adjustments to the Official Poverty Measure.
Thousands of adults in Arkansas lost insurance coverage in the first six months after Medicaid work requirements were implemented, with no change in employment.